Evidence mapPaperPMID 36930656Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2023

High-plasma soluble prorenin receptor is associated with vascular damage in male, but not female, mice fed a high-fat diet.

Bruna Visniauskas, Virginia Reverte, Caleb M Abshire, Benard O Ogola, Carla B Rosales, Michelle Galeas-Pena, Venkata N Sure, Siva S V P Sakamuri, Nicholas R Harris, Isabella Kilanowski-Doroh and 6 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Bruna VisniauskasDepartment of Physiology, Tulane University School of Medicine, New Orleans, Louisiana, United States.ORCID 0000-0002-4525-2194
Virginia ReverteDepartment of Physiology, Tulane University School of Medicine, New Orleans, Louisiana, United States.ORCID 0000-0003-3225-6476
Caleb M AbshireDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.
Benard O OgolaDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.ORCID 0000-0002-6084-6986
Carla B RosalesDepartment of Physiology, Tulane University School of Medicine, New Orleans, Louisiana, United States.
Michelle Galeas-PenaDepartment of Physiology, Tulane University School of Medicine, New Orleans, Louisiana, United States.ORCID 0000-0002-9257-3222
Venkata N SureDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.ORCID 0000-0002-3657-962X
Siva S V P SakamuriDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.ORCID 0000-0003-3569-9985
Nicholas R HarrisDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.
Isabella Kilanowski-DorohDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.
Alexandra B McnallyDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.ORCID 0000-0001-5516-4991
Alec C HortonDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.
Margaret ZimmermanDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.
Prasad V G KatakamDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.ORCID 0000-0002-4708-9140
Sarah H LindseyDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States.ORCID 0000-0002-9837-4582
Minolfa C PrietoDepartment of Physiology, Tulane University School of Medicine, New Orleans, Louisiana, United States.ORCID 0000-0002-0199-3193
Tulane University · US

Funding

Interplay of Sex Hormones and Chromosomes in Vascular Oxidative Stress and Arterial StiffeningK99HL155841 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI Benard Ojwang Ogola · 2022 to 2022
$85k
NHLBI NIH HHS K99 HL155841NHLBI NIH HHS R00 HL155841NHLBI NIH HHS R01 HL133619NIDDK NIH HHS R01 DK104375NIGMS NIH HHS P30 GM103337NINDS NIH HHS R01 NS094834
6 · The paper itself

Abstract

Plasma soluble prorenin receptor (sPRR) displays sexual dimorphism and is higher in women with type 2 diabetes mellitus (T2DM). However, the contribution of plasma sPRR to the development of vascular complications in T2DM remains unclear. We investigated if plasma sPRR contributes to sex differences in the activation of the systemic renin-angiotensin-aldosterone system (RAAS) and vascular damage in a model of high-fat diet (HFD)-induced T2DM. Male and female C57BL/6J mice were fed either a normal fat diet (NFD) or an HFD for 28 wk to assess changes in blood pressure, cardiometabolic phenotype, plasma prorenin/renin, sPRR, and ANG II. After completing dietary protocols, tissues were collected from males to assess vascular reactivity and aortic reactive oxygen species (ROS). A cohort of male mice was used to determine the direct contribution of increased systemic sPRR by infusion. To investigate the role of ovarian hormones, ovariectomy (OVX) was performed at 32 wk in females fed either an NFD or HFD. Significant sex differences were found after 28 wk of HFD, where only males developed T2DM and increased plasma prorenin/renin, sPRR, and ANG II. T2DM in males was accompanied by nondipping hypertension, carotid artery stiffening, and aortic ROS. sPRR infusion in males induced vascular thickening instead of material stiffening caused by HFD-induced T2DM. While intact females were less prone to T2DM, OVX increased plasma prorenin/renin, sPRR, and systolic blood pressure. These data suggest that sPRR is a novel indicator of systemic RAAS activation and reflects the onset of vascular complications during T2DM regulated by sex.

Indexed as

Diabetes Mellitus, Type 2HypertensionVacuolar Proton-Translocating ATPasesAnimalsBlood PressureCarubicinDiet, High-FatFemaleMaleMiceMice, Inbred C57BLProrenin ReceptorReactive Oxygen SpeciesReceptors, Cell SurfaceReninRenin-Angiotensin SystemCarubicinN-formyl-13-dihydrocarminomycinProrenin ReceptorReactive Oxygen SpeciesReceptors, Cell SurfaceReninVacuolar Proton-Translocating ATPasescardiovascular complicationscircadian rhythmsreactive oxygen speciesrenin-angiotensin-aldosterone systemvascular dysfunction

Identifiers

PMID36930656
PMCPMC10151046
OpenAlexW4327675426

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.